2021
DOI: 10.1186/s40246-021-00326-3
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy

Abstract: COVID-19 has engulfed the world and it will accompany us all for some time to come. Here, we review the current state at the milestone of 1 year into the pandemic, as declared by the WHO (World Health Organization). We review several aspects of the on-going pandemic, focusing first on two major topics: viral variants and the human genetic susceptibility to disease severity. We then consider recent and exciting new developments in therapeutics, such as monoclonal antibodies, and in prevention strategies, such a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
41
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(43 citation statements)
references
References 116 publications
2
41
0
Order By: Relevance
“…In 2020, the COVID-19 has been declared a Public Health Emergency of international concern by the World Health Organization (WHO). To reduce the number of SARS-CoV-2 infections, different countries have adopted restrictive anti-contagion measures (lockdown, continuous use of facial masks, social distancing, and reduction of social activities) [ 10 12 , 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…In 2020, the COVID-19 has been declared a Public Health Emergency of international concern by the World Health Organization (WHO). To reduce the number of SARS-CoV-2 infections, different countries have adopted restrictive anti-contagion measures (lockdown, continuous use of facial masks, social distancing, and reduction of social activities) [ 10 12 , 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the past months, several publications have identified loci and genes associated with COVID-19 susceptibility for severe COVID-19 by using comprehensive GWAS studies or genome, exome or candidate gene analyses (5). However, most of these susceptibility alleles showed risk values too low (odds ratio <2) to be regarded as predictive genomic markers.…”
Section: Introductionmentioning
confidence: 99%
“…However, most of these susceptibility alleles showed risk values too low (odds ratio <2) to be regarded as predictive genomic markers. Some of the loci reported include ABO blood group (6, 7), ACE2 (8), TMPRSS2 (8), several HLA alleles (5,9), APOE (10), and IFITM3 (11). On the other hand, rare variants in genes encoding for members of the type I/III interferon (IFN) pathway showed a higher estimated risk to severe COVID-19 (12,13).…”
Section: Introductionmentioning
confidence: 99%
“…In the pandemic era of the coronavirus disease 2019 (COVID- 19), the scientific interdisciplinary discourse on various coping strategies has largely been conducted by policymakers and their advisors. This has resulted in many opinions and views that often differ from scientific facts.…”
Section: Introductionmentioning
confidence: 99%